Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giovanni Baraldi

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
Journal of Medicinal Chemistry|January 5, 2002
7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubilityPier Giovanni Baraldi, Barbara Cacciari, Romeo Romagnoli, et al.
International Journal of Molecular Medicine|December 17, 2008
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: induction of production of fetal hemoglobin in human erythroid precursor cellsNicoletta Bianchi, Monica Borgatti, Eitan Fibach, et al.
Current Medicinal Chemistry|June 25, 2005
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A3 adenosine receptors in human tumor cell linesPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Romeo Romagnoli, et al.
Letters in Drug Design & Discovery|August 3, 2010
Synthesis and Evaluation of Haloacetyl, α-Bromoacryloyl and Nitrooxyacetyl Benzo[b]furan and Benzo[b]thiophene Derivatives as Potent Antiproliferative Agents Against Leukemia L1210 and K562 CellsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Pharmacology & Therapeutics|October 11, 2003
A glance at adenosine receptors: novel target for antitumor therapyStefania Merighi, Prisco Mirandola, Katia Varani, et al.
Neoplasia (New York, N.Y.)|October 2, 2009
A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicinStefania Merighi, Carolina Simioni, Stefania Gessi, et al.
European Journal of Medicinal Chemistry|October 7, 2004
Synthesis of 2-amino-3-heteroaroylthiophenes and evaluation of their activity as potential allosteric enhancers at the human A1 receptorPier Giovanni Baraldi, Maria Giovanna Pavani, John C Shryock, et al.
Neoplasia (New York, N.Y.)|October 26, 2005
A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 24, 2005
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2Pier Giovanni Baraldi, Romeo Romagnoli, Mojgan Aghazadeh Tabrizi, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2005
Synthesis and biological characterization of [3H] (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)-(4-chlorophenyl)-methanone, the first radiolabelled adenosine A1 allosteric enhancerPier Giovanni Baraldi, Maria Giovanna Pavani, Edward Leung, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
Journal of Medicinal Chemistry|January 5, 2002
7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubilityPier Giovanni Baraldi, Barbara Cacciari, Romeo Romagnoli, et al.
International Journal of Molecular Medicine|December 17, 2008
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: induction of production of fetal hemoglobin in human erythroid precursor cellsNicoletta Bianchi, Monica Borgatti, Eitan Fibach, et al.
Current Medicinal Chemistry|June 25, 2005
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A3 adenosine receptors in human tumor cell linesPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Romeo Romagnoli, et al.
Letters in Drug Design & Discovery|August 3, 2010
Synthesis and Evaluation of Haloacetyl, α-Bromoacryloyl and Nitrooxyacetyl Benzo[b]furan and Benzo[b]thiophene Derivatives as Potent Antiproliferative Agents Against Leukemia L1210 and K562 CellsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Pharmacology & Therapeutics|October 11, 2003
A glance at adenosine receptors: novel target for antitumor therapyStefania Merighi, Prisco Mirandola, Katia Varani, et al.
Neoplasia (New York, N.Y.)|October 2, 2009
A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicinStefania Merighi, Carolina Simioni, Stefania Gessi, et al.
European Journal of Medicinal Chemistry|October 7, 2004
Synthesis of 2-amino-3-heteroaroylthiophenes and evaluation of their activity as potential allosteric enhancers at the human A1 receptorPier Giovanni Baraldi, Maria Giovanna Pavani, John C Shryock, et al.
Neoplasia (New York, N.Y.)|October 26, 2005
A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 24, 2005
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2Pier Giovanni Baraldi, Romeo Romagnoli, Mojgan Aghazadeh Tabrizi, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2005
Synthesis and biological characterization of [3H] (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)-(4-chlorophenyl)-methanone, the first radiolabelled adenosine A1 allosteric enhancerPier Giovanni Baraldi, Maria Giovanna Pavani, Edward Leung, et al.
Pageof 16